Contingency management in opioid substitution treatment;Kontingenzmanagement in der Substitutionsbehandlung Opiatabhängiger

Fortschritte der Neurologie Psychiatrie

Volumn 79, Issue 7, 2011, Pages 395-403

  Specka, M ^a   Boning A ^a   Scherbaum, N ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

comorbid substance related disorders; contingency management; opiate dependence; psychotherapy

Indexed keywords

ARTICLE; COGNITIVE THERAPY; DETOXIFICATION; DRUG USE; HUMAN; OPIATE ADDICTION; OPIATE SUBSTITUTION TREATMENT; REINFORCEMENT; UNITED STATES; ADDICTION; GERMANY; LEARNING; META ANALYSIS; METHODOLOGY; PATIENT CARE; PSYCHOLOGICAL ASPECT; REVIEW;

GERMANY; HUMANS; LEARNING; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PATIENT CARE MANAGEMENT; REINFORCEMENT, SOCIAL; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 79960103914     PISSN: 07204299     EISSN: 14393522     Source Type: Journal    
DOI: 10.1055/s-0029-1245810     Document Type: Article

References (57)

1. Kunstmann W, Hessenauer F. Substitution Opiatabhängiger: Versorgung wird schwieriger. Dtsch Arztebl 2009 106 A-1508 /B-1289 /C-1257
2. Senay E C. Opioids: Methadone maintenance. Galanter M Kleber H D. (ed.) Textbook of Substance Abuse Treatment. Washington American Psychiatric Press 2005 271-279
3. Wittchen H U., Apelt S M., Soyka M et al. Feasibility and outcome of substitution treatment of heroin-dependent patients in specialized substitution centers and primary care facilities in Germany: a naturalistic study in 2694 patients. Drug Alcohol Depend 2008 95 245-257
4. Verthein U, Haasen C, Prinzleve M et al. Cocaine use and the utilisation of drug help services by consumers of the open drug scene in Hamburg. Eur Addict Res 2001 7 176-183 (Pubitemid 34042818)
5. Backmund M, Schütz C G., Meyer K et al. Alcohol consumption in heroin users, methadone-substituted and codeine-substituted patients frequency and correlates of use. Eur Addict Res 2003 9 45-50 (Pubitemid 36160296)
6. Backmund M, Meyer K, Henkel C et al. Co-consumption of benzodiazepines in heroin users, methadone-substituted and codeine-substituted patients. J Addict Dis 2005 24 17-29 (Pubitemid 43334176)
7. Raschke P. Substitutionstherapie. Ergebnisse langfristiger Behandlung von Opiatabhängigen. Freiburg i. Br Lambertus 2005
8. Stitzer M, Petry N. Contingency management for treatment of substance abuse. Annu Rev Clin Psychol 2006 2 411-434 (Pubitemid 43799812)
9. Perrez M, Zbinden M. Lernen. Ehlers A Hahlweg K (Hrsg.) Grundlagen der Klinischen Psychologie. Göttingen Hogrefe 1996 301-349
10. Silverman K, Higgins S T., Brooner R K. et al. Sustained cocaine abstinence in methadone maintenance patients through voucher-based reinforcement therapy. Arch Gen Psychiatry 1996 53 409-415 (Pubitemid 26149229)
11. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd. ed. Hillsdale, NJ Lawrence Erlbaum Associates 1988
12. Griffith G A., Rowan-Szal R R., Roark D D. Contingency management in outpatient methadone treatment: Meta-Analysis. Drug Alcohol Depend 2000 58 55-66
13. Prendergast M, Podus D, Finney J et al. Contingency management for treatment of substance use disorder: a meta-analysis. Addiction 2006 101 1546-1560 (Pubitemid 44527186)
14. Lussier J P., Heil S H., Mongeon J A. et al. A meta-analysis of voucher-based reinforcement therapy for substance use disorders. Addiction 2006 101 192-203 (Pubitemid 43351594)
15. Dutra L, Stathopoulou G, Basden S L. et al. A meta-analytic review of psychosocial interventions for substance use disorders. Am J Psychiatry 2008 165 179-187 (Pubitemid 351704516)
16. Sofuoglu M, Gonzalez G, Poling J et al. Prediction of treatment outcome by baseline urine cocaine results and self-reported cocaine use for cocaine and opioid dependence. Am J Drug Alcohol Abuse 2003 29 713-727 (Pubitemid 37549402)
17. Stitzer M L., Iguchi M Y., Felch L J. Contingent take-home incentive: effects on drug use of methadone maintenance patients. J Consult Clin Psychol 1992 60 927-934
18. Preston K L., Silverman K, Higgins S T. et al. Cocaine use early in treatment predicts outcome in a behavioral treatment program. J Consult Clin Psychol 1998 66 691-696 (Pubitemid 28387761)
19. Chutuape M A., Silverman K, Stitzer M. Use of methadone take-home contingencies with persistent opiate and cocaine abusers. J Subst Abuse Treat 1999 16 23-30 (Pubitemid 29021881)
20. Stitzer M L., Peirce J, Petry N M. et al. Abstinence-based incentives in methadone maintenance: interaction with intake stimulant test results. Exp Clin Psychopharmacol 2007 15 344-350 (Pubitemid 47445262)
21. Dallery J, Silverman K, Chutuape M A. et al. Voucher-based reinforcement of opiate plus cocaine abstinence in treatment-resistant methadone patients: effects of reinforcer magnitude. Exp Clin Psychopharmacol 2001 9 317-325 (Pubitemid 32762879)
22. Preston K L., Umbricht A, Wong C J. et al. Shaping cocaine abstinence by successive approximation. J Consult Clin Psychol 2001 69 643-654 (Pubitemid 32803852)
23. Piotrowski N A., Tusel D J., Sees K L. et al. Contingency contracting with monetary reinforcers for abstinence from multiple drugs in a methadone program. Exp Clin Psychopharmacol 1999 7 399-411
24. Stitzer M L., Bigelow G E., Liebson I A. et al. Contingent reinforcement for benzodiazepine-free urines: evaluation of a drug abuse treatment intervention. J Appl Behav Anal 1982 15 493-503
25. Iguchi M Y., Stitzer M L., Bigelow G E. et al. Contingency management in methadone maintenance: effects of reinforcing and aversive consequences on illicit polydrug use. Drug Alcohol Depend 1988 22 1-7
26. Silverman K, Robles E, Mudric T et al. A randomized trial of long-term reinforcement of cocaine abstinence in methadone-maintained patients who inject drugs. J Consult Clin Psychol 2004 72 839-854 (Pubitemid 39299446)
27. Petry N M., Martin B. Low-cost contingency management for treating cocaine-abusing methadone patients. J Consult Clin Psych 2002 70 398-405 (Pubitemid 34274884)
28. Peirce J M., Petry N M., Stitzer M L. et al. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study. Arch Gen Psychiatry 2006 63 201-208 (Pubitemid 43213882)
29. Kidorf M, Brooner R K., King V L. et al. Concurrent validity of cocaine and sedative dependence diagnosis in opioid-dependent outpatients. Drug Alcohol Depend 1996 42 117-123 (Pubitemid 26312890)
30. Rhodes G L., Saules K K., Helmus T C. et al. Improving on-time counseling attendance in a methadone treatment program: a contingency management approach. Am J Drug Alcohol Abuse 2003 29 759-773 (Pubitemid 37549405)
31. Villano C L., Rosenblum A, Magura S et al. Improving treatment engagement and outcomes for cocaine-using methadone patients. Am J Drug Alcohol Abuse 2002 28 213-230 (Pubitemid 34457056)
32. Kidorf M, Stitzer M L., Brooner R K. et al. Contingent methadone take-home doses reinforce adjunct therapy attendance of methadone maintenance patients. Drug Alcohol Depend 1994 36 221-226 (Pubitemid 24357602)
33. Iguchi M Y., Belding M A., Morral A R. et al. Reinforcing operants other than abstinence in drug abuse treatment: an effective alternative for reducing drug use. J Consult Clin Psychol 1997 65 421-428 (Pubitemid 27246783)
34. Petry N M., Martin B, Cooney J L. et al. Give them prizes and they will come: contingency management for the treatment of alcohol dependence. J Consult Clin Psychol 2000 68 250-257
35. Petry N M., Tedford J, Austin M et al. Prize reinforcement contingency management for treating cocaine user: how low can we go, and with whom? Addiction 2004 99 349-360 (Pubitemid 38333827)
36. Petry N M., Peirce J M., Stitzer M L. et al. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study. Arch Gen Psychiatry 2005 62 1148-1156 (Pubitemid 41396940)
37. Petry N M., Martin B, Simcic F. Prize reinforcement contingency management for cocaine dependence: integration with group therapy in a methadone clinic. J Consult Clin Psychol 2005 73 354-359 (Pubitemid 40446393)
38. Rogers R E., Higgins S T., Silverman K et al. Abstinence-contingent reinforcement and engagement in non-drug-related activities among illicit drug abusers. Psychol Addict Behav 2008 22 544-550
39. Ferster C B., Skinner B F. Schedules of reinforcement. Englewood Cliffs, NJ Prentice Hall 1957
40. Chutuape M A., Silverman K, Stitzer M. Effects of urine testing frequency on outcome in a methadone take-home contingency program. Drug Alcohol Depend 2001 62 69-76 (Pubitemid 32149966)
41. Preston K L., Ghitza U E., Schmittner J P. et al. Randomized trial comparing two treatment strategies using prize-based reinforcement of abstinence in cocaine and opiate users. J Appl Behav Anal 2008 41 551-563
42. Ghitza U E., Epstein D H., Schmittner J et al. Effect of Reinforcement Probability and Prize Size on Cocaine and Heroin Abstinence in Prize-Based Contingency Management. J Appl Behav Anal 2008 41 539-549
43. Roll J M., Huber A, Sodano A R. et al. A comparison of five reinforcement schedules for use in contingency management-based treatment of methamphetamine abuse. Psychol Rec 2006 56 67-81 (Pubitemid 43258349)
44. Silverman K, Wong C J., Umbricht-Schneiter A et al. Broad beneficial effects of cocaine abstinence reinforcement among methadone patients. J Consult Clin Psychol 1998 66 811-824 (Pubitemid 28478349)
45. Bundesärztekammer. Richtlinien der Bundesärztekammer zur Durchführung der substitutionsgestützten Behandlung Opiatabhängiger. Dtsch Arztebl 2002 99 B1218-1221; novellierte Version: Deutsches Ärzteblatt 2010; 107: A511A516
46. Havemann-Reinecke U, Küfner H, Schneider U et al. AWMF-Leitlinien: Postakutbehandlung bei Störungen durch Opioide. Sucht 2004 50 226-257 (Pubitemid 39128301)
47. Kirby K C., Benishek L A., Dugosh K L. et al. Substance abuse treatment providers beliefs and objections regarding contingency management: Implications for dissemination. Drug Alcohol Depend 2006 85 19-27 (Pubitemid 44376548)
48. Scherbaum N, Kluwig J, Meiering C et al. Use of illegally acquired medical opioids by opiate-dependent patients in detoxification treatment. Eur Addict Res 2005 11 193-196 (Pubitemid 41191614)
49. Bechara A, Damasio H. Decision-making in addiction (part I): impaired activation of somatic states in substance-dependent individuals when pondering decisions with negative future consequences. Neuropsychologia 2002 40 1675-1689 (Pubitemid 34462876)
50. Rosenblum A, Foote J, Magura S et al. Follow-up of inpatient cocaine withdrawal for cocaine-using methadone patients. J Subst Abuse Treat 1996 13 467-470 (Pubitemid 27264292)
51. Specka M, Scherbaum N. Ergebnisse der stationären Entzugsbehandlung von Benzodiazepinen bei Methadonsubstituierten. Sucht 2005 51 329-338
52. Chutuape M A., Silverman K, Stitzer M. Contingent reinforcement sustains post-detoxification abstinence from multiple drugs: a preliminary study with methadone patients. Drug Alcohol Depend 1999 54 69-81 (Pubitemid 29073380)
53. Wurst F M., Dürsteler-MacFarland K M., Auwaerter V et al. Assessment of alcohol use among methadone maintenance patients by direct ethanol metabolites and self-reports. Alcohol Clin Exp Res 2008 32 1552-1557
54. Broers B, Giner F, Dumont P et al. Inpatient opiate detoxification in Geneva: follow-up at 1 and 6 months. Drug Alcohol Depend 2000 58 85-92
55. Rosenblum A, Magura S, Foote J et al. Treatment intensity and reduction in drug use for cocaine-dependent methadone patients: a dose-response relationship. J Psychoactive Drugs 1995 27 151-159
56. Rawson R A., Huber A, McCann M J. et al. A comparison of contingency management and cognitive-behavioral approaches during methadone maintenance treatment for cocaine dependence. Arch Gen Psychiatry 2002 59 817-824 (Pubitemid 35001147)
57. Scherbaum N, Kluwig J, Specka M et al. Group Psychotherapy for Opiate Addicts in Methadone Maintenance Treatment A Controlled Trial. Eur Addict Res 2005 11 163-171 (Pubitemid 41191610)